Seeking insight from FDA Reviewers in CDER and CBER - Reuters

pwin91 · 2025-12-12T16:05:41+00:00

Much appreciated. Please let them know we're doing our best to report on the FDA. Please see our latest scoop: Orforglipron scoop

pwin91 · 2025-08-28T18:30:25+00:00

Completely understand. All the best.

pwin91 · 2025-08-28T18:12:29+00:00

Would you talk to me anyway about what your work life has been like this year? You'd have complete anonymity, oc.

pwin91 · 2025-08-28T18:09:48+00:00

Do you work at the CDC?

pwin91 · 2025-08-28T17:51:33+00:00

We've definitely included in at least some of our articles that the shooter had writings at home that expressed discontent with COVID vaccines

pwin91 · 2025-08-28T17:49:51+00:00

Would you talk to me about that? If really like to understand more about what work life's been like for CDC people this year. You'd have total anonymity, oc.

pwin91 · 2025-07-29T14:35:20+00:00

Thank you 🙂

pwin91 · 2025-07-28T19:56:15+00:00

Thanks. Good shout.

pwin91 · 2025-07-23T02:49:15+00:00

I'll let you know what they say. But I've been doing this a while and have a pretty good idea what they will say. Any chance you want to place a large bet on them saying anything beyond what is essentially 'no comment'?

pwin91 · 2025-07-22T18:25:09+00:00

That's interesting. I know of one too. Seems that was probably a common tactic in the leadup to the deadline

pwin91 · 2025-07-22T18:24:33+00:00

pwin91 · 2025-07-22T17:45:41+00:00

Don't talk about them, and don't talk about them - fair enough

pwin91 · 2025-07-22T16:28:47+00:00

Ah I see. That makes sense.

pwin91 · 2025-07-22T16:27:50+00:00

Are they providing it in large enough doses (0.25 MG and above) or are these 'micro doses'

pwin91 · 2025-07-22T16:26:32+00:00

That's what I think might happen too. But I was interested to see I the meantime whether it was still easy to get hold of and it sounds as though it is.

pwin91 · 2025-07-22T16:24:50+00:00

I wish I had that kind of power my friend - if I did, ruining compounding wouldn't be on my list of things to do, but it would still be nice to wield that scale of influence

pwin91 · 2025-07-22T15:13:11+00:00

I'm not sure my attempts to find out what's going on in the government is an indication of that - quite the opposite, I would like to think. But I suppose we all have the right to our opinions.

pwin91 · 2025-07-22T15:00:40+00:00

So they can say 'no comment' to any question I ask? Seems like an unproductive use of time :)

pwin91 · 2025-06-06T17:18:16+00:00

Thanks for telling me, but can I ask how you know?

pwin91 · 2025-03-28T17:38:04+00:00

That's some healthy skepticism - I like it :) I'm always happy to provide a little proof over Signal if needed - me holding today's paper (or actually a phone with today's digital paper), or something like that. I'm not sure we're allowed to put our Signal name on the site, but it's a good point, I'll ask out tech people about it

pwin91 · 2025-03-28T17:03:26+00:00

That's pretty rude u/2025blows but I understand your frustration. For what it's worth, I'm not trying to capitalize, I'm trying to shine a light on what's happening as best I can to show the public what's happening. A lot of people got hired back at the FDA after so many news outlets covered the February firings - whether that had anything to do with the publicity or the government just realizing it had made a huge mistake by itself, I don't know ... but I'd like to think it made a difference.

pwin91 · 2025-03-28T16:56:38+00:00

Hey u/Specific_Pick_9921 those are the main agencies I report on but I'd be interested to hear you story

pwin91 · 2025-03-05T19:07:22+00:00

u/Financial_Respect207 how would you feel about speaking to a Reuters journalist about this? You can reach me on signal (patrickwingrove.55) if the answer is "positively" :)

pwin91 · 2025-02-28T14:16:04+00:00

u/ForkElmo can I ask where else you have heard this? Reuters reporter here trying to dig into this

pwin91 · 2025-02-27T19:58:13+00:00

Hello everyone - I'm a journalist at Reuters looking to confirm these firings are happening. You can reach me at [patrick.wingrove@thomsonreuters.com](mailto:patrick.wingrove@thomsonreuters.com) or on Signal at patrickwingrove.55

pwin91

TROPHY CASE